At Oklahoma Cancer Specialists and Research Institute, we are proud to be a leader in cancer treatment, research and patient care. Our practice has been recognized by some of the leading U.S. cancer research, technology and standards groups.
MD Anderson Cancer Network®
Oklahoma Cancer Specialists and Research Institute is a certified member of MD Anderson Cancer Network®, a program of MD Anderson Cancer Center. MD Anderson is world-renowned for its pioneering evidence-based treatment plans for cancer care, prevention, research and education. OCSRI provides local access to nationally ranked cancer-fighting expertise. Learn More.
Oklahoma Cancer Specialists and Research Institute is a certified cancer center by the Quality Oncology Practice Initiative (QOPI), an affiliate of the American Society of Clinical Oncology (ASCO). QOPI certification is given to outpatient hematology-oncology practices that meet the highest standards for quality. OCSRI is only the second cancer center in Oklahoma to achieve this recognition.
The QOPI® Certification Program (QCPTM) was launched in January 2010, with more than 200 practices already certified. This certification for outpatient oncology practices is the first program of its kind for oncology in the United States. Oncologists can achieve certification by meeting the highest standards of care. The QCP seal designates those practices that not only scored high on the key QOPI quality measures, but meet rigorous chemotherapy safety standards established by ASCO and the Oncology Nursing Society (ONS). Learn More
Federally Funded Cancer Research
Oklahoma Cancer Specialists and Research Institute is proud to support the American Society of Clinical Oncology (ASCO) and their efforts to bring awareness to the importance of federal funding for cancer research. For more information on the importance of funding cancer research, please visit this link.
Accuray Luminary Site
Oklahoma Cancer Specialists and Research Institute is a designated Accuray Luminary Site, offering Accuray’s TomoTherapy technology. TomoTherapy is a fully integrated, 3DCRT (3D conformal radiation therapy) and IMRT system, designed to provide each patient with highly accurate, quality individualized treatment using daily CT imaging and optimized beamlet-based delivery. The system’s unique helical design enables it to treat a broader range of tumors, expanding radiation therapy options for more patients.